Compare WEST & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEST | INMD |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | Israel |
| Employees | 1393 | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.4M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | WEST | INMD |
|---|---|---|
| Price | $8.08 | $15.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | $7.00 | ★ $17.33 |
| AVG Volume (30 Days) | 434.5K | ★ 616.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.27 | $1.74 |
| Revenue Next Year | $10.66 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.59 | $12.72 |
| 52 Week High | $10.19 | $16.74 |
| Indicator | WEST | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.38 | 53.59 |
| Support Level | $7.73 | $13.27 |
| Resistance Level | $8.54 | $15.23 |
| Average True Range (ATR) | 0.43 | 0.30 |
| MACD | 0.10 | -0.06 |
| Stochastic Oscillator | 77.36 | 26.99 |
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider mainly in the United States. Additionally, it offers coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice, restaurant, convenience store, travel center, non-commercial account, and hospitality industries around the world. The company's reportable segments are: Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment, which offers beverage solutions, including coffee, tea, flavors, extracts, and ingredients. Geographically, the company generates maximum revenue from its business in the United States and the rest from other countries.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.